Field Efficacy of an Attenuated Infectious Bronchitis Variant 2 Virus Vaccine in Commercial Broiler Chickens

Egyptian poultry suffer from frequent respiratory disease outbreaks associated with Infectious Bronchitis Virus (IBV) variant 2 strains (Egy/VarII). Different vaccination programs using imported vaccines have failed to protect the flocks from field challenge. Recent studies confirmed a successful protection using homologous strains as live attenuated vaccines. In this study, a newly developed live attenuated IB-VAR2 vaccine representing the GI-23 Middle East IBV lineage was evaluated in day-old commercial broilers in an IBV-endemic area. A commercial broiler flock was vaccinated with the IB-VAR2 vaccine at day-old age followed by IB-H120 at day 16. The vaccinated flock was monitored on a weekly basis till the slaughter age. The health status and growth performance were monitored, and selected viral pathogen real-time RT-PCR (rRT-PCR) detection was conducted on a weekly basis. Finally, the flock was compared to a nearby farm with only the classical IB-H120 vaccination program. Results showed that the IB-VAR2 vaccine was tolerable in day-old broiler chicks. The IBV virus rRT-PCR detection was limited to the trachea as compared to its nephropathogenic parent virus. Respiratory disease problems and high mortalities were reported in the IB-H120-only vaccinated flock. An exposure to a wild-type Egy/VarII strain was confirmed in both flocks as indicated by partial IBV S1 gene sequence. Even though the IB-VAR2-vaccinated flock performance was better than the flock that received only IB-H120, the IBV ELISA (enzyme-linked immunosorbent assay) and log2 Haemagglutination inhibition (HI) antibody mean titers remained high (3128 ± 2713 and ≥9 log2, respectively) until the 28th day of age. The current study demonstrates the safety and effectiveness of IB-VAR2 as a live attenuated vaccine in day-old commercial broilers. Also, the combination of IB-VAR2 and classical IBV vaccines confers a broader protective immune response against IBV in endemic areas.

[1]  Mohamed A. Zain El-Abideen,et al.  Protective Efficacy of Different Live Attenuated Infectious Bronchitis Virus Vaccination Regimes Against Challenge With IBV Variant-2 Circulating in the Middle East , 2019, Front. Vet. Sci..

[2]  K. Subbarao,et al.  Influenza , 2017, The Lancet.

[3]  H. Geerligs,et al.  Protection of chickens vaccinated with combinations of commercial live infectious bronchitis vaccines containing Massachusetts, Dutch and QX-like serotypes against challenge with virulent infectious bronchitis viruses 793B and IS/1494/06 Israel variant 2 , 2017, Avian pathology : journal of the W.V.P.A.

[4]  A. Arafa,et al.  The sequence of the full spike S1 glycoprotein of infectious bronchitis virus circulating in Egypt reveals evidence of intra-genotypic recombination , 2016, Archives of Virology.

[5]  A. Arafa,et al.  Genotyping and pathotyping of diversified strains of infectious bronchitis viruses circulating in Egypt. , 2016, World journal of virology.

[6]  Ahmed Ali,et al.  Prevalence of avian respiratory viruses in broiler flocks in Egypt , 2016, Poultry Science.

[7]  M. Baylis,et al.  Heterologous live infectious bronchitis virus vaccination in day-old commercial broiler chicks: clinical signs, ciliary health, immune responses and protection against variant infectious bronchitis viruses , 2016, Avian pathology : journal of the W.V.P.A.

[8]  E. Holmes,et al.  S1 gene-based phylogeny of infectious bronchitis virus: An attempt to harmonize virus classification , 2016, Infection, Genetics and Evolution.

[9]  M. Baylis,et al.  Experimental infection of IS/885/00-like infectious bronchitis virus in specific pathogen free and commercial broiler chicks , 2016, Research in Veterinary Science.

[10]  Jiaqiang Wu,et al.  Attenuation mechanism of virulent infectious bronchitis virus strain with QX genotype by continuous passage in chicken embryos. , 2016, Vaccine.

[11]  M. Baylis,et al.  Protection conferred by live infectious bronchitis vaccine viruses against variant Middle East IS/885/00-like and IS/1494/06-like isolates in commercial broiler chicks , 2015, Veterinary Record Open.

[12]  Jing Zhao,et al.  Safety and efficacy of an attenuated Chinese QX-like infectious bronchitis virus strain as a candidate vaccine , 2015, Veterinary Microbiology.

[13]  M. Baylis,et al.  Immune responses and interactions following simultaneous application of live Newcastle disease, infectious bronchitis and avian metapneumovirus vaccines in specific-pathogen-free chicks. , 2015, Research in veterinary science.

[14]  A. C. Alessi,et al.  Humoral and cell-mediated immune responses to different doses of attenuated vaccine against avian infectious bronchitis virus. , 2013, Viral immunology.

[15]  A. S. Abdel-Moneim,et al.  Emergence of a novel genotype of avian infectious bronchitis virus in Egypt , 2012, Archives of Virology.

[16]  Soliman,et al.  Preparation and Evaluation of Master Seed for infectious bronchitis vaccine from local variant isolate , 2012 .

[17]  J. Ouédraogo,et al.  Prevalence of infectious bronchitis and Newcastle disease virus among domestic and wild birds in H5N1 outbreaks areas. , 2011, Journal of infection in developing countries.

[18]  I. Davidson,et al.  Development of a real-time TaqMan RT-PCR assay for the detection of H9N2 avian influenza viruses. , 2010, Journal of virological methods.

[19]  Chang-Seon Song,et al.  Characterization of a novel live attenuated infectious bronchitis virus vaccine candidate derived from a Korean nephropathogenic strain , 2010, Vaccine.

[20]  Veterinary Collage.  Isolation and Characterization of Nephropathogenic Strain of Infectious Bronchitis Virus in EGYPT , 2010 .

[21]  M. Mancin,et al.  Pathogenicity of a QX strain of infectious bronchitis virus in specific pathogen free and commercial broiler chickens, and evaluation of protection induced by a vaccination programme based on the Ma5 and 4/91 serotypes , 2008, Avian pathology : journal of the W.V.P.A.

[22]  K. Asasi,et al.  Coinfection of avian influenza virus (H9N2 subtype) with infectious bronchitis live vaccine , 2008, Archives of Virology.

[23]  J. Gelb,et al.  Evaluating Viral Interference Between Infectious Bronchitis Virus and Newcastle Disease Virus Vaccine Strains Using Quantitative Reverse Transcription–Polymerase Chain Reaction , 2007, Avian diseases.

[24]  I. Brown,et al.  Validated H5 Eurasian Real-Time Reverse Transcriptase–Polymerase Chain Reaction and Its Application in H5N1 Outbreaks in 2005–2006 , 2007, Avian diseases.

[25]  D. Cavanagh.  Coronavirus avian infectious bronchitis virus. , 2007, Veterinary research.

[26]  A. S. Abdel-Moneim,et al.  S1 gene sequence analysis of a nephropathogenic strain of avian infectious bronchitis virus in Egypt , 2006, Virology Journal.

[27]  D. Swayne,et al.  Development and evaluation of a real-time Taqman RT-PCR assay for the detection of infectious bronchitis virus from infected chickens , 2006, Journal of Virological Methods.

[28]  D. Cavanagh.  Coronaviruses in poultry and other birds , 2005, Avian pathology : journal of the W.V.P.A.

[29]  B. Ladman,et al.  S1 gene characteristics and efficacy of vaccination against infectious bronchitis virus field isolates from the United States and Israel (1996 to 2000) , 2005, Avian pathology : journal of the W.V.P.A.

[30]  D. Suarez,et al.  Development of a Real-Time Reverse-Transcription PCR for Detection of Newcastle Disease Virus RNA in Clinical Samples , 2004, Journal of Clinical Microbiology.

[31]  J. D. de Wit,et al.  Sensitivity and specificity of serological tests for infectious bronchitis virus antibodies in broilers. , 1997, Avian pathology : journal of the W.V.P.A.

[32]  P. Dawson,et al.  Antibody responses to a live Newcastle disease vaccine when combined with a live infectious bronchitis vaccine , 1972, Veterinary Record.